92 related articles for article (PubMed ID: 17582262)
1. [Effects of topiramate and valproate acid on serum insulin and leptin levels in young and adult rats].
Li J; Li D; Huang SP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):229-32. PubMed ID: 17582262
[TBL] [Abstract][Full Text] [Related]
2. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
3. [Effects of valproate acid on blood lipid, serum leptin and cerebral cortex in juvenile and adult rats].
Li J; Li D; Huang SP
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):479-82. PubMed ID: 20540861
[TBL] [Abstract][Full Text] [Related]
4. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K
Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963
[TBL] [Abstract][Full Text] [Related]
5. [An experimental study on hepatotoxicity of topiramate in young rats].
Huang J; Ren RN; Chen XM; Ye LY
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):54-8. PubMed ID: 17306079
[TBL] [Abstract][Full Text] [Related]
6. Differential cognitive and behavioral effects of topiramate and valproate.
Meador KJ; Loring DW; Hulihan JF; Kamin M; Karim R;
Neurology; 2003 May; 60(9):1483-8. PubMed ID: 12743236
[TBL] [Abstract][Full Text] [Related]
7. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy.
Wang-Tilz Y; Tilz C; Wang B; Tilz GP; Stefan H
Epilepsia; 2006 Feb; 47(2):233-9. PubMed ID: 16499746
[TBL] [Abstract][Full Text] [Related]
8. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.
Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K
Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice.
Lalonde J; Samson P; Poulin S; Deshaies Y; Richard D
Physiol Behav; 2004 Jan; 80(4):415-20. PubMed ID: 14741225
[TBL] [Abstract][Full Text] [Related]
10. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
[TBL] [Abstract][Full Text] [Related]
11. Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential.
Sun W; Wang Y; Wang W; Wu X
Int J Psychophysiol; 2008 Jun; 68(3):235-41. PubMed ID: 18378030
[TBL] [Abstract][Full Text] [Related]
12. The effects of topiramate and sex hormones on energy balance of male and female rats.
Richard D; Picard F; Lemieux C; Lalonde J; Samson P; Deshaies Y
Int J Obes Relat Metab Disord; 2002 Mar; 26(3):344-53. PubMed ID: 11896489
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
14. Topiramate increases the risk of valproic acid-induced encephalopathy.
Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
[TBL] [Abstract][Full Text] [Related]
15. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats.
Wilkes JJ; Nelson E; Osborne M; Demarest KT; Olefsky JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E617-24. PubMed ID: 15536205
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin and leptin levels in valproate-associated obesity.
Pylvänen V; Knip M; Pakarinen A; Kotila M; Turkka J; Isojärvi JI
Epilepsia; 2002 May; 43(5):514-7. PubMed ID: 12027912
[TBL] [Abstract][Full Text] [Related]
17. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of carbamazepine, valproate and topiramate in the treatment of medial temporal epilepsy in children].
Boldyreva SR; Ermakov AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):41-7. PubMed ID: 20517209
[TBL] [Abstract][Full Text] [Related]
19. Does long-term use of valproate cause weight gain in prepubertal epileptic children?
Caksen H; Deda G; Berberoğlu M
Int J Neurosci; 2002 Oct; 112(10):1183-9. PubMed ID: 12587521
[TBL] [Abstract][Full Text] [Related]
20. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
